Open Labs Fellow/s

Richard Thomson - Nuria Antón - Mireia Ferrer

Project Participant/s

Nuria Antón - Richard Thomson

GSK’s contribution

GSK has a group working on the P.vivax culture and the CRESIB and GSK scientists will work in close collaboration. This project will require work in the GSK Biosafety level 3 facilities at Tres Cantos.

Project Description

This two-year project is focused on creating a continuous lab-based supply of the P. vivax malaria parasite in the blood stage. If successful this project will offer a technological breakthrough that could facilitate further advances in research on P. vivax and potentially lead to a new era in P.vivax malaria drug discovery.

Publications 1

---